BackMallinckrodt Plc - New Overview

Mallinckrodt Plc - New Other Current Assets

Track Mallinckrodt Plc - New's other current assets ($430M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$431.60M
282.96% YoYΔ $318.90M vs prior year quarter

Peer average / median

Loading

Mallinckrodt Plc - New Other Current Assets History

Loading

Mallinckrodt Plc - New vs. peers: Other Current Assets Comparison

Loading

Mallinckrodt Plc - New Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Mallinckrodt Plc - New (MNK) FAQ

The latest other current assets for MNK is $430M as of June 2026. That compares with $110M in the prior-year period — up 283.0% year over year. Investors often review this figure alongside Mallinckrodt Plc - New's historical trend and sector peers before judging valuation or financial health.

Over the past year, MNK's other current assets moved from $110M to $430M — a 283.0% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Mallinckrodt Plc - New's operating scale or balance-sheet position.

A other current assets figure of $430M for MNK is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MNK's other current assets ($430M), review year-over-year change from $110M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Mallinckrodt Plc - New's other current assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.